Table 3 Longitudinal study of the STLV-1 seroprevalence in JMs
Age in 2011 (Age in 2015) | Number of seronegative in 2011 | Number of seropositive in 2015 | Frequency of seroconversion |
|---|---|---|---|
0 (4) | 7 | 6 | Â |
1 (5) | 1 | 1 | Â |
2 (6) | 6 | 6 | Â |
3 (7) | 4 | 3 | Â |
0–3 (4–7) | 18 | 16 | 16/18 (89%) |
4 (8) | 3 | 3 | Â |
5 (9) | 1 | 1 | Â |
6 (10) | 3 | 3 | Â |
≥ 7 (≥ 11) | 3 | 1 |  |
≥ 4 (≥ 8) | 10 | 8 | 8/10 (80%) |
Total | 28 | 24 | 24/28 (86%) |